Keywords: Spectroscopy, Treatment Response, Gastroesophageal Cancer, Metastases
Motivation: Patients with metastatic gastroesophageal cancer(GEC) have a poor prognosis. Timely treatment response evaluation could prevent continuation of ineffective treatment and improve quality of life.
Goal(s): To compare treatment-induced changes in 31P MRSI PME/PDE ratios in liver metastases of GEC between baseline and after 2 weeks of treatment with CT-based response evaluation at 9 weeks.
Approach: Four patients with liver metastases of GEC who received first-line systemic therapy underwent 31P MRSI at 7 Tesla at baseline and after 2 weeks of treatment.
Results: Poor response at 9 weeks was associated with increased PME/PDE after 2 weeks, whereas good response was associated with decreased PME/PDE.
Impact: This study shows promising results of 31P MRSI to evaluate systemic therapy response after only 2 weeks in patients with liver metastases of gastroesophageal cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords